Tutorials
NRX Pharmaceuticals Inc logo

NRX Pharmaceuticals Inc

$ 0.80 -0.0078 (-0.97%) 08:08 PM EST
P/E:
At Loss
P/B:
1.68
Market Cap:
$ 53.29M
Enterprise V:
$ 13.61M
Volume:
1.39M
Avg Vol (2M):
3.57M
Also Trade In:
Volume:
1.39M
Market Cap $:
53.29M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.57M
Enterprise Value $:
13.61M
PB Ratio:
1.68
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

NRX Pharmaceuticals Inc
NAICS : 541714 SIC : 2834
1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801
Description
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.
Name Current Vs Industry Vs History
Cash-To-Debt 77.31
Equity-to-Asset 0.73
Debt-to-Equity 0.02
Debt-to-EBITDA -0.01
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 65.16
9-Day RSI 63.78
14-Day RSI 60.22
6-1 Month Momentum % -77.89
12-1 Month Momentum % -96.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.66
Quick Ratio 3.66
Cash Ratio 3.37

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -3060.48
ROA % -231.28
ROIC % -675.3
ROCE % -727.55

Financials (Next Earnings Date:2022-08-15)

NRXP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:NRXP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -7.21
Beta 0
Volatility % 96.03
14-Day RSI 60.22
14-Day ATR ($) 0.086663
20-Day SMA ($) 0.66635
12-1 Month Momentum % -96.33
52-Week Range ($) 0.4899 - 18.3
Shares Outstanding (Mil) 66.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NRX Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More